Comparison of baseline-nitrate technetium-99m sestamibi with rest- redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 384-391

  Sciagrà, Roberto ^a,b   Bisi, Gianni ^a,b   Santoro, Giovanni M ^b   Zerauschek, Francesca ^a,b   Sestini, Stelvio ^a,b   Pedenovi, Paola ^b   Pappagallo, Ruggiero ^a,b   Fazzini, Pier Filippo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; NITRATES; PROGNOSIS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030855439     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00192-7     Document Type: Article

References (33)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J. 117:1988;211-221.
2. Tillisch JH, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
3. Brunken RC, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol. 10:1987;557-567.
4. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection comparison with positron emission tomography using fluorine-18 deoxyglucose . J Nucl Med. 32:1991;673-678.
5. Grandin C, Wijns W, Melin JA, et al. Delineation of myocardial viability with PET. J Nucl Med. 36:1995;1543-1552.
6. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Segal BL. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol. 51:1983;1312-1316.
7. Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects an accurate marker of myocardial viability . J Am Coll Cardiol. 12:1988;1456-1463.
8. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146.
9. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med. 32:1991;1718-1724.
10. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
11. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol. 71:1993;166-172.
12. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi . Circulation. 89:1994;2552-2561.
13. Charney R, Schwinger ME, Chun J, et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J. 128:1994;864-869.
14. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 82:1990;1826-1838.
15. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 82:1990;1424-1437.
16. Beanlands RSB, Dawood F, Wen W-H, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation. 82:1990;1802-1814.
17. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med. 33:1992;1925-1930.
18. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile . J Nucl Med. 33:1992;505-511.
19. Dondi M, Tartagni F, Fallani F, et al. A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography possible implications for myocardial viability detection in infarcted patients . Eur J Nucl Med. 20:1993;26-31.
20. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m-sestamibi defects. J Am Coll Cardiol. 23:1994;92-98.
21. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol. 75:1995;1214-1219.
22. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease comparison of 99mTc-sestamibi with thallium reinjection and [18F] fluorodeoxyglucose . Circulation. 89:1994;578-587.
23. Altehoefer C, von Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability comparison with fluorine-18-FDG PET . J Nucl Med. 35:1994;569-574.
24. Worsley DF, Fung AY, Jue J, Burns RJ. Identification of viable myocardium with technetium-99m-MIBI infusion. J Nucl Med. 36:1995;1037-1039.
25. Maurea S, Cuocolo A, Soricelli A, et al. Myocardial viability index in chronic coronary artery disease technetium-99m-methoxy isobutyl isonitrile redistribution . J Nucl Med. 36:1995;1953-1960.
26. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates feasibility and reliability for prediction of postrevascularization outcome of asynergic territories . J Am Coll Cardiol. 24:1994;1282-1289.
27. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med. 36:1995;1994-2000.
28. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med. 36:1995;1945-1952.
29. Hill TC, Holman BL. Discriminant function analysis toward a more rigorous approach to SPECT interpretation . J Nucl Med. 35:1994;1455-1456.
30. Picano E, Marzullo P, Gigli G, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol. 70:1992;703-710.
31. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
32. Afifi AA, Clark V. Computer-Aided Multivariate Analysis. 1984;246-286 Von Nostrand Company, New York.
33. Armstrong W. Echocardiography in coronary heart disease. Prog Cardiovasc Dis. 30:1988;267-288.